Weight Loss

Novo Nordisk seeks orders to block Eli Lilly weight-loss drug ads

Lilly on Friday denied any wrongdoing, saying it stood by its advertising and would vigorously defend itself. Novo and Lilly are battling for dominance in the obesity drug market

GLP-1 opportunity to lift domestic business at Indian pharmaceutical firms

The expanding domestic market for semaglutide-based weight-loss drugs is expected to help cushion weaker US sales for Cipla and Dr Reddy's after the loss of Revlimid exclusivity

Why Nestlé is changing its flavours because of weight-loss drugs

GLP-1 weight-loss drugs are changing more than just waistlines, they're changing how food tastes. And that's forcing food giant Nestlé to rethink its products.

Explained: Why Nestle is tweaking flavours for people taking GLP-1 drugs

Nestle's chefs are working with people taking GLP-1 drugs to develop new flavour combinations, including potentially using more spices and pepper to compensate for dulled taste perception

GLP-1 rush exposes capacity crunch at India's drug manufacturing firms

Demand for GLP-1 drugs such as semaglutide is exposing capacity gaps across peptide APIs, sterile fill-finish facilities, injector devices and glass cartridges

India's GLP-1 market enters slower growth phase after semaglutide surge

After a near fourfold expansion driven by generic semaglutide launches, India's GLP-1 market is showing signs of moderation as patient onboarding growth slows

France becomes first EU country to reimburse anti-obesity drugs: Minister

Patients in France are currently paying around €300 ​per month on average for the drugs, she said, without indicating how many people currently follow such treatments

Does sweating more mean you're burning more fat? Experts bust fitness myth

Heavy sweating may feel like proof of an effective workout, but experts say fat loss depends on far more than perspiration alone

Eli Lilly's Mounjaro overtakes Merck's Keytruda as world's top-selling drug

Mounjaro generated $8.7 billion for Lilly in the first quarter of 2026, outperforming Merck's Keytruda, which posted sales of $7.9 billion

Fake Mounjaro injection manufacturing racket busted in Gurugram; 2 arrested

Authorities have unearthed a racket involving the manufacturing and sale of "fake" Mounjaro (tirzepatide) injections and arrested two persons here in this connection, an official said on Monday. A nationwide alert has been issued to detect the counterfeit injections and an investigation is underway to unravel the entire network, including all those involved in this racket, Drug Control Officer Amandeep Chauhan said. He said a Health Department team raided a residential society in Sector 62 on Monday and arrested two people, including the key accused. The accused were importing raw drugs from China and manufacturing counterfeit injections of Mounjaro. The entire racket was being run from a flat in the society. The accused supplied these illegal injections through the B2B portal Indiamart, the officer alleged. Mounjarois a weekly injectable medication for type 2 diabetesthat significantly improves blood sugar control and aids weight loss. "We received information about a fake inject

Lilly backs regulatory action after fake Mounjaro seizure in Gurugram

Drugmaker highlights patient safety risks and pledges cooperation with authorities after seizure of suspected counterfeit Mounjaro products in Gurugram

Hetero Labs targets sales of 1.5 million semaglutide pens in global rollout

Hetero plans to launch the drug in India in ‌April, focusing on building market share overseas to begin with, Managing Director Vamsi Krishna Bandi said

As risky as obesity? How losing too much body fat can harm your health

New research shows that losing fat the wrong way can disrupt metabolism, trigger inflammation, and increase long-term disease risk, challenging the idea that less fat is always better

The rise of ‘Mounjaro brides’: How weight loss injections are entering India’s wedding economy

From bridal skincare to fitness makeovers, India’s pre-wedding industry is evolving fast. Now, weight-loss injections like Mounjaro are becoming part of that transformation, raising questions about he

From treatment to trend, slimming drug boom sparks misuse concerns

Doctors caution against cosmetic misuse of GLP-1 drugs as cheaper generics boost access, raising risks of unsupervised use and short-term weight-loss trends

Eli Lilly's Mounjaro sales dip as semaglutide generics flood Indian market

Mounjaro sales in March dropped to ₹114 crore ($12.3 million) in March from ₹135 crore a month earlier, Pharmarack data show

Can Ozempic and similar weight loss drugs cause hair loss? Experts explain

Experts explain the science behind hair loss reports, noting that the shedding is usually temporary and linked to how the body responds to rapid weight loss

Centre increases monitoring of weight-loss drugs, flags safety concerns

Regulators have been asked to track adverse events as India tightens oversight on popular obesity drugs amid rising demand and concerns over misuse and misleading promotions

India's 'Mounjaro brides': Weight-loss injections enter pre-wedding prep

Many marriages are still arranged by families, often accompanied by expectations around physical appearance and financial status, which is driving a growing demand for weight-loss solutions

Cheap, accessible, powerful: The promise and peril of semaglutide in India

Cheap, accessible, and powerful semaglutide is changing India’s weight-loss and diabetes landscape. But as prices crash and access expands, the risks also increase